Characterization of c-Maf transcription factor in normal and neoplastic hematolymphoid tissue and its relevance in plasma cell neoplasia

American Journal of Clinical Pathology

Volumn 132, Issue 3, 2009, Pages 361-371

  Natkunam, Yasodha ^a   Tedoldi, Sara ^b   Paterson, Jennifer C ^b   Zhao, Shuchun ^a   Rodriguez Justo, Manuel ^c   Beck, Andrew H ^a   Siebert, Reiner ^d   Mason, David Y ^b   Marafioti, Teresa ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

c Maf; Immunohistochemistry; Myeloma; Plasma cell; Tissue microarray

Indexed keywords

TRANSCRIPTION FACTOR C MAF; MAF PROTEIN, HUMAN; TUMOR MARKER;

ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER TISSUE; CHROMOSOME REARRANGEMENT; CHRONIC LYMPHATIC LEUKEMIA; CLASSICAL HODGKIN LYMPHOMA; CONTROLLED STUDY; FOLLICULAR LYMPHOMA; GENE EXPRESSION PROFILING; HAIRY CELL LEUKEMIA; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPH NODE; LYMPHATIC SYSTEM TUMOR; LYMPHOBLASTOMA; LYMPHOID TISSUE; MANTLE CELL LYMPHOMA; MULTIPLE MYELOMA; NATURAL KILLER CELL; NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPLEEN; T CELL LYMPHOMA; THYMUS; TONSIL; UPREGULATION; BIOSYNTHESIS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENETICS; LYMPHOMA; METABOLISM; PALATINE TONSIL; WESTERN BLOTTING;

BLOTTING, WESTERN; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA; MULTIPLE MYELOMA; PALATINE TONSIL; PROTO-ONCOGENE PROTEINS C-MAF; TUMOR MARKERS, BIOLOGICAL;

EID: 69849098998     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPEAGDKLWDMB1O     Document Type: Article

References (40)

1. Jaffe ES, Harris NL, Stein H, et al, eds. Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001. World Health Organization Classification of Tumours.
2. Kuehl WM, Bergsagel PL. Multiple myeloma: evolving genetic events and host interactions. Nat Rev Cancer. 2002;2:175-187.
3. Bergsagel PL, Kuehl WM. Molecular pathogenesis and a consequent classification of multiple myeloma. J Clin Oncol. 2005;23:6333-6338.
4. Kuehl WM, Bergsagel PL. Early genetic events provide the basis for a clinical classification of multiple myeloma. Hematology Am Soc Hematol Educ Program. 2005:346-352.
5. Chesi M, Bergsagel PL, Shonukan OO, et al. Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma. Blood. 1998;91:4457-4463.
6. Hurt EM, Wiestner A, Rosenwald A, et al. Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma. Cancer Cell. 2004;5:191-199.
7. O'Connell FP, Pinkus JL, Pinkus GS. CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms. Am J Clin Pathol. 2004;121:254-263.
8. Natkunam Y, Warnke RA, Montgomery K, et al. Analysis of MUM1/IRF4 protein expression using tissue microarrays and immunohistochemistry. Mod Pathol. 2001;14:686-694.
9. Cattoretti G, Angelin-Duclos C, Shaknovich R, et al. PRDM1/ BLIMP-1 is expressed in human B-lymphocytes committed to the plasma cell lineage. J Pathol. 2005;206:76-86.
10. Garcia JF, Roncador G, Garcia JF, et al. PRDM1/ BLIMP-1 expression in multiple B and T-cell lymphoma. Haematologica. 2006;91:467-474.
11. Tedoldi S, Paterson JC, Hansmann ML, et al. Transmembrane adaptor molecules: a new category of lymphoid-cell markers. Blood. 2006;107:213-221.
12. Natkunam Y, Lossos IS, Taidi B, et al. Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation. Blood. 2005;105:3979-3986.
13. Marafioti T, Pozzobon M, Hansmann ML, et al. Expression of intracellular signaling molecules in classical and lymphocyte predominance Hodgkin disease. Blood. 2004;103:188-193.
14. Marafioti T, Pozzobon M, Hansmann ML, et al. The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas. Br J Haematol. 2005;128:333-342.
15. Saez B, Martin-Subero JI, Odero MD, et al. Multicolor interphase cytogenetics for the study of plasma cell dyscrasias. Oncol Rep. 2007;18:1099-1106.
16. Eisen MB, Spellman PT, Brown PO, et al. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A. 1998;95:14863-14868.
17. Nishizawa M, Kataoka K, Goto N, et al. v-maf, a viral oncogene that encodes a "leucine zipper" motif. Proc Natl Acad Sci U S A. 1989;86:7711-7715.
18. Hegde SP, Zhao J, Ashmun RA, et al. c-Maf induces monocytic differentiation and apoptosis in bipotent myeloid progenitors. Blood. 1999;94:1578-1589.
19. Ho IC, Hodge MR, Rooney JW, et al. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell. 1996;85:973-983.
20. Kim JI, Ho IC, Grusby MJ, et al. The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines. Immunity. 1999;10:745-751.
21. Tsuchiya M, Taniguchi S, Yasuda K, et al. Potential roles of large mafs in cell lineages and developing pancreas. Pancreas. 2006;32:408-416.
22. Yang Y, Cvekl A. Tissue-specific regulation of the mouse alphaA-crystallin gene in lens via recruitment of Pax6 and c-Maf to its promoter. J Mol Biol. 2005;351:453-469.
23. Morito N, Yoh K, Fujioka Y, et al. Overexpression of c-Maf contributes to T-cell lymphoma in both mice and human. Cancer Res. 2006;66:812-819.
24. Pouponnot C, Sii-Felice K, Hmitou I, et al. Cell context reveals a dual role for Maf in oncogenesis. Oncogene. 2006;25:1299-1310.
25. Fabris S, Agnelli L, Mattioli M, et al. Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses. Genes Chromosomes Cancer. 2005;42:117-127.
26. Rasmussen T, Knudsen LM, Dahl IM, et al. C-MAF oncogene dysregulation in multiple myeloma: frequency and biological relevance. Leuk Lymphoma. 2003;44:1761-1766.
27. Mattioli M, Agnelli L, Fabris S, et al. Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma. Oncogene. 2005;24:2461-2473.
28. Gutierrez NC, Hernandez JM, Garcia JL, et al. Differences in genetic changes between multiple myeloma and plasma cell leukemia demonstrated by comparative genomic hybridization. Leukemia. 2001;15:840-845.
29. Perez-Andres M, Almeida J, Martin-Ayuso M, et al. Clonal plasma cells from monoclonal gammopathy of undetermined significance, multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immunological bone marrow microenvironment. Leukemia. 2005;19:449-455.
30. Chang H, Sloan S, Li D, et al. Genomic aberrations in plasma cell leukemia shown by interphase fluorescence in situ hybridization. Cancer Genet Cytogenet. 2005;156:150-153.
31. Stewart AK, Fonseca R. Prognostic and therapeutic significance of myeloma genetics and gene expression profiling. J Clin Oncol. 2005;23:6339-6344.
32. Basso K, Liso A, Tiacci E, et al. Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors. J Exp Med. 2004;199:59-68.
33. Tiacci E, Liso A, Piris M, et al. Evolving concepts in the pathogenesis of hairy-cell leukaemia. Nat Rev Cancer. 2006;6:437-448.
34. Di Bella N, Ravandi F. Purine analogue combinations for indolent lymphomas. Semin Hematol. 2006;43(2 suppl 2):S11-S21.
35. Wanko SO, de Castro C. Hairy cell leukemia: an elusive but treatable disease. Oncologist. 2006;11:780-789.
36. Went PT, Zimpfer A, Pehrs AC, et al. High specificity of combined TRAP and DBA.44 expression for hairy cell leukemia. Am J Surg Pathol. 2005;29:474-478.
37. Falini B, Tiacci E, Liso A, et al. Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). Lancet. 2004;363:1869-1870.
38. Tsuboi K, Iida S, Inagaki H, et al. MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies. Leukemia. 2000;14:449-456.
39. Kallies A, Hawkins ED, Belz GT, et al. Transcriptional repressor BLIMP-1 is essential for T cell homeostasis and self-tolerance. Nat Immunol. 2006;7:466-474.
40. Martins GA, Cimmino L, Shapiro-Shelef M, et al. Transcriptional repressor BLIMP-1 regulates T cell homeostasis and function. Nat Immunol. 2006;7:457-465.